Patent · US Active

PD-L1 promoter methylation in cancer

US11254987B2 · kind B2 · utility

1Cited by

55References

20Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Edward Kadel · South San Francisco, US
Marcin KOWANETZ · San Francisco, US
Kimberly Walter · South San Francisco, US

Key dates

Filing date	Nov 22, 2017
Grant date	Feb 22, 2022
Priority date	—
Expiry date	Jan 7, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/154
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This invention provides methods for the treatment of cancer in subjects having medium or low methylation level in the PD-L1 promoter region. Also provided are related kits and articles of manufacture.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.